Loading…
Codexis, Inc. is projected to rise to $3.28 by 2027, a +24% move from its current price of $2.64. CDXS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.54 | $2.64 | $2.75 | +0.06% |
| May 30 | $2.50 | $2.64 | $2.79 | +0.12% |
| May 31 | $2.47 | $2.64 | $2.83 | +0.17% |
| Jun 1 | $2.45 | $2.65 | $2.86 | +0.23% |
| Jun 2 | $2.43 | $2.65 | $2.89 | +0.29% |
| Jun 3 | $2.41 | $2.65 | $2.91 | +0.35% |
| Jun 4 | $2.39 | $2.65 | $2.94 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.39 | $2.65 | $2.94 | +0.41% |
| Week 2 | $2.30 | $2.66 | $3.08 | +0.82% |
| Week 3 | $2.24 | $2.67 | $3.19 | +1.23% |
| Week 4 | $2.18 | $2.68 | $3.30 | +1.64% |
| Week 5 | $2.14 | $2.69 | $3.39 | +2.05% |
| Week 6 | $2.10 | $2.71 | $3.48 | +2.47% |
| Week 7 | $2.07 | $2.72 | $3.57 | +2.88% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Codexis, Inc. is a healthcare company that provides technology solutions for therapeutics manufacturing. It leverages its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes across a broad geographic footprint.
The ECO Synthesis manufacturing platform enables the scaled manufacture of RNAi therapeutics through an enzymatic route. The company holds a license agreement with Aldevron LLC and Pfizer Inc. Codexis was incorporated in 2002 and is headquartered in Redwood City, California.
Codexis, Inc. (CDXS) operates in the Healthcare sector. Its current price is $2.49 and its market capitalization stands at $226.33M, with a rank of 3763. The stock trades within a 30-day range of $1.91 to $3.25, reflecting notable volatility within a relatively tight price band.
A major floor 62.9% below — a decisive break under it would weaken the trend.
The nearest floor, 8.7% below — buyers have tended to step in here.
The nearest ceiling, 8.0% above — a clean break opens room to run.
A major ceiling 16.4% above — clearing it would confirm fresh momentum.
Key CDXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CDXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.57 | Buy | $2.58 | Buy |
| MA 10 | $2.54 | Buy | $2.57 | Buy |
| MA 20 | $2.61 | Buy | $2.55 | Buy |
| MA 50 | $2.29 | Buy | $2.31 | Buy |
| MA 100 | $1.84 | Buy | $2.11 | Buy |
| MA 200 | $2.04 | Buy | $2.15 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.58 | Neutral |
| Stoch RSI (14) | 40.44 | Neutral |
| CCI (20) | 20.10 | Neutral |
| Williams %R (14) | -53.85 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -7.37 | Sell |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 46.15 | Neutral |
| TRIX (15) | 0.53 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 59.58 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 2.58 | Buy |
| ADX (14) | 17.00 | Neutral |
| ATR (14) | 0.10 | Info |
The near-term technical picture is bullish, with sentiment labeled as BULLISH. The RSI14 is 50, and the short-term trend is framed by the SMA50 at $2.25 and the SMA200 at $2.04. Support sits at $2.30 and resistance at $2.85, suggesting a defined range for the immediate horizon.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.98 | $2.64 | $3.90 | 0% | Neutral | |
| $2.49 | $3.28 | $4.62 | +24% | Bullish | |
| $2.50 | $3.42 | $5.06 | +30% | Bullish | |
| $2.60 | $3.69 | $5.67 | +40% | Bullish | |
| $2.65 | $3.88 | $6.15 | +47% | Bullish | |
| $3.45 | $5.20 | $8.47 | +97% | Bullish | |
| $4.21 | $6.51 | $10.86 | +146% | Bullish | |
| $4.27 | $6.78 | $11.57 | +157% | Bullish | |
| $4.34 | $7.05 | $12.27 | +167% | Bullish | |
| $4.30 | $7.15 | $12.69 | +171% | Bullish | |
| $6.70 | $12.45 | $23.89 | +372% | Bullish | |
| $10.71 | $23.81 | $51.05 | +802% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.98 | $2.64 | $3.15 | +0.00% |
| June 2026 | $2.37 | $2.80 | $3.42 | +6.24% |
| July 2026 | $2.32 | $2.78 | $3.46 | -0.76% |
| August 2026 | $2.32 | $2.82 | $3.55 | +1.17% |
| September 2026 | $2.41 | $2.94 | $3.76 | +4.48% |
| October 2026 | $2.39 | $2.94 | $3.79 | -0.05% |
| November 2026 | $2.32 | $2.87 | $3.74 | -2.28% |
| December 2026 | $2.39 | $2.97 | $3.90 | +3.49% |
Click any year to see its month-by-month CDXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Codexis, Inc.'s 2026 outlook centres on $2.64, within a $0.98 to $3.90 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, CDXS could reach as high as $4.62, with a base case around $3.28 and support toward $2.49 — roughly +24% from $2.64. Momentum favours further upside here.
Expect CDXS to range from $2.50 to $5.06 through 2028. The $3.42 average target implies a +30% move from current prices. That is up +4% on the projected 2027 average. Buyers look set to stay in control over this stretch.
The CDXS price prediction for 2029 points to an average of $3.69 (low $2.60, high $5.67) — a potential gain of +40% on today's $2.64. Momentum favours further upside here.
In 2030, CDXS is projected to trade between $2.65 and $6.15, averaging $3.88 — a potential gain of +47% from today's $2.64. That is up +5% on the projected 2029 average. Buyers look set to stay in control over this stretch.
Codexis, Inc.'s 2031 outlook centres on $5.20, within a $3.45 to $8.47 range. That is up +34% on the projected 2030 average. That marks a +97% change versus current levels. Momentum favours further upside here.
By 2032, CDXS could reach as high as $10.86, with a base case around $6.51 and support toward $4.21 — roughly +146% from $2.64. Buyers look set to stay in control over this stretch.
Expect CDXS to range from $4.27 to $11.57 through 2033. The $6.78 average target implies a +157% move from current prices. That is up +4% on the projected 2032 average. Momentum favours further upside here.
The CDXS price prediction for 2034 points to an average of $7.05 (low $4.34, high $12.27) — a potential gain of +167% on today's $2.64. Buyers look set to stay in control over this stretch.
In 2035, CDXS is projected to trade between $4.30 and $12.69, averaging $7.15 — a potential gain of +171% from today's $2.64. That is up +1% on the projected 2034 average. Momentum favours further upside here.
Codexis, Inc.'s 2040 outlook centres on $12.45, within a $6.70 to $23.89 range. That is up +74% on the projected 2035 average. That marks a +372% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, CDXS could reach as high as $51.05, with a base case around $23.81 and support toward $10.71 — roughly +802% from $2.64. Momentum favours further upside here.
Investing $1,000 in CDXS today (≈ 378.787879 CDXS) could be worth
$9,018.39
+$8,018.39 (+802%) by 2050 · US Dollar
Based on the average projected CDXS price of $23.81 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CDXSwould be worth at today's price.
$1,000 invested in CDXS on May 27, 2025 (≈ 392.15687 CDXS) would be worth
$1,035.29
+$35.29 (+3.5%) today · 1.04× · US Dollar
Based on a CDXS entry price of $2.55 vs. today's $2.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.58 | $1,023.26 | +2.3% |
| 1 month ago | $2.65 | $996.23 | -0.4% |
| 3 months ago | $1.07 | $2,467.29 | +146.7% |
| 6 months ago | $1.73 | $1,526.01 | +52.6% |
| 1 year ago | $2.55 | $1,035.29 | +3.5% |
| All time (5.0y) ago | $20.62 | $128.03 | -87.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CDXS forecast.
Our base-case forecast reaches $5.30 around 2032.
Implied market cap at $5.30: $481.75M
The multi-year forecast shows upside potential with a rising path from 2026 through 2050. In 2026 the avg is $2.49 with an ROI of 0 and neutral sentiment. By 2027 the avg is $3.07 with a 23.4% ROI and bullish momentum, followed by 2028 at $3.16 (27.1% ROI) and 2029 at $3.44 (38.2% ROI).
The 2030 forecast projects an avg of $3.55 with a 42.5% ROI, and bullish sentiment persists. In 2031 the avg jumps to $4.77 (91.6% ROI), then 2032 at $6.04 (142.6% ROI) and 2033 at $6.17 (147.9% ROI). The trajectory continues in 2034 with an avg of $6.43 (158.2% ROI) and 2035 at $6.58 (164.2% ROI).
The long-range view strengthens markedly: 2040 shows an avg of $11.27 (352.4% ROI) and 2050 an avg of $21.51 (763.9% ROI), with continued bullish sentiment across these horizons. These figures are estimates, not guarantees, and reflect projected upside over time alongside inherent investment uncertainty.
Tap a question to reveal the answer.
Avg $3.55, min $2.40, max $5.68; ROI 42.5%; sentiment BULLISH.
Forecasts show bullish momentum driven by higher expected prices in later years (e.g., 2031–2050), with 2026 avg $2.49 and 0% ROI, but 2030 avg $3.55 and 42.5% ROI as a milestone. These are estimates and not guarantees.
Yes. Forecasts project max values around $10.19 in 2032, $10.65 in 2033, and $11.33 in 2034.
Current price is $2.49 with a market cap of $226.33M and a rank of 3763.
The 30-day range is $1.91 to $3.25.
Codexis, Inc. Community Discussion
0Share your Codexis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.